Detalhe da pesquisa
1.
[Analysis of treatment modalities and prognosis of patients with gallbladder cancer in China from 2010 to 2017].
Zhonghua Wai Ke Za Zhi
; 58(9): 697-706, 2020 Sep 01.
Artigo
Chinês
| MEDLINE | ID: mdl-32878417
2.
[Efficacy and safety analysis of the zanubrutinib-based bridging regimen in chimeric antigen receptor T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma].
Zhonghua Xue Ye Xue Za Zhi
; 44(10): 813-819, 2023 Oct 14.
Artigo
Chinês
| MEDLINE | ID: mdl-38049332